[EN] TARGETED CONJUGATES COMPRISING MODIFIED SIRNA<br/>[FR] CONJUGUÉS CIBLÉS CONPRENANT UN ARNSI MODIFIÉ
申请人:[en]ARBUTUS BIOPHARMA CORPORATION
公开号:WO2022098990A1
公开(公告)日:2022-05-12
The invention provides certain nucleic acids (e.g., double stranded siRNA molecules), as well as conjugates that comprise a targeting moiety, an siRNA, and optional linking groups. The conjugates are useful to target siRNA.